ZI-MA4-1 clinical trials

A study to test the safety, tolerability and effect of ZI-MA4-1 for patients with locally advanced or metastatic solid malignancies

This study is testing a new cell therapy called ZI-MA4-1 for certain advanced cancers. It's the first time humans will receive it, so doctors are checking its safety and the right dose. It's hoped to offer a new treatment option where current ones are limited.